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THE DEFENCE MECHANISM IN 
MALIGNANT DISEASE
R. D. Hunter. B.Sc.
From  a dissertation read before the Society on November 6th, 1968
T h e  original suggestion im plicating im ­
m unological factors in the natural h istory of 
m alignant disease has been ascribed to Paul 
Ehrlich (1 ). C onfirm ation  o f this concept has 
w aited fifty  years for developm ents in  know ­
ledge and technique but its application allows 
not only som e understanding of observed 
phenom ena, but speculation on a rational 
approach to treatm ent and on a scientific 
establishm ent of the aetiological factors in­
volved.
T rad ition al teaching defines this group of 
conditions by the type of tissue change in­
volved, the degree of differentiation and extent 
o f spread. From  these a prognosis is assessed 
and the clin ical p icture tends to be one of 
steady progression, interrupted by therapeutic 
endeavour, but cu lm inating in the death of 
the patient. V ariations on this picture arc 
seen in clinical practice.
CLINICAL PHENOMENA
Everson (2) has collected a series of 13 0  
fu lly  docum ented eases in w hich unequivocal 
regression of the neoplasm  was observed in 
spite o f no effective treatm ent. H istologically 
proved metastases have been seen to regress 
after treatm ent o f the prim ary lesion (3), and 
m etastatic deposits from  breast neoplasm s 
often recur m any years after treatm ent of the 
prim ary lesion (4).
C onsidering the opposite end of the spec­
trum , transplantation of m alignant neoplastic 
tissue from  one hum an host to another has 
been a notoriously unsuccessful procedure ( 5)
b ut transplantation of tissue containing neo­
plastic cells in the face o f im m unological sup­
pression has resulted in the rapid proliferation 
of the neoplasm  w ithin  the new  host (6, 7) 
and apparent reversal o f this phenom enon has 
been seen w hen the suppression was dis­
con tinu ed  (8).
T h ese  exam ples, im plicating im m unological 
reactions betw een the host m echanism  and the 
neoplastic cell, im ply  som e alteration in the 
antigenicity of the neoplastic cells. Specific 
tolerance, by the host, o f its own tissue anti­
gens is a very w ell substantiated thesis(9) and 
the absence of them  has been dem onstrated 
for a variety of neoplastic tissues(1 ). E v id ­
ence fo r the developm ent of new  antigens has 
been sought for in investigations exam ining 
b oth  specific effector m echanism s of the im ­
m unological system ; hum oral antibody and the 
im m unologically com petent cells ( 11).
In hum an disease there arc exam ples o f the 
detection o f specific antibody to neoplastic 
cells(10 ) and o f the qualitative relationship 
betw een them  and the extent o f the disease 
process(1 1 ). A  strong case has been m ade on 
the basis o f anim al experim ents, im plicating 
hum oral antibody in the natural history of 
neoplasia(1 2) but the cellu lar nature of the 
infiltration, w hen view ed in the light o f the 
lack of role for antibody in the hom ograft 
reaction(1 3), and recent concepts o f the pos­
sible role fo r hum oral antibody in the conse­
quences of cell d eath (1 4) makes any interpret­
ation of the results im possible at present.
A N I M A L  E X P E R I M E N T S
U n fortun ately the function o f the inununo- 
logically com petent cells has proved m ore 
difficult to study and no reliable direct test of 
this m echanism  has becom e available. T h e  
m ethod which has given rise to the break­
through in this field has been the transplant­
ation of neoplasm s betw een m em bers o f allo­
geneic strains o f anim als. T h e ir  genetic 
sim ilarity allow s tissue to be transplanted 
from  one to another w ithin the strain with 
im punity , but F o le y  ( 1 5) dem onstrated that a 
carcinogen induced neoplasm  w ould be reject­
ed if the anim al had previously been exposed 
to the sam e neoplasm . T h is  rejection was 
show n to be a function of sensitized lym pho- 
cytes(1 6), thus conform ing to the criteria for 
a hom ograft reaction, i.e. d ifferent antigens 
m ust have been present. T h e  work has been 
confirm ed w ith different anim als and different 
carcinogens ( 17 , 18) w ith  the additional dem on­
stration of the antigenic independence of each 
individual neoplasm .
R epetition  o f this work w ith viral induced 
neoplasm s in anim als has allow ed the dem on­
stration o f tum our specific antigens ( 19 ) as be­
fore but a very significant difference b ecam e 
apparent w hen the new  antigenicity was 
shown to be identical in  all the neoplasm s 
induced by the sam e group o f viruses (20 ) and 
d ifferent w hen various groups were contrasted 
(21).
In view  of the artificial m ethod of neoplasm  
induction used in these experim ents the 
results m ight be view ed w ith  som e suspicion 
but the dem onstration o f this rejection pheno­
m enon in a spontaneous tum our arising in an 
allogeneic strain of an im als (2 1 ) and in recent 
sophisticated experim ents involving hum an 
neoplasm s (23) makes the acceptance of the 
general concept m uch easier.
I M P L I C A T I O N S  ON E A R L Y  N E O P L A S M  G R O W T H
W h ile  the reality o f neoplasm  specific anti­
gens accords w ith experim ental results and 
explains clin ical phenom ena, the presence 
w ithin  an im m unologically  m ature individual 
o f a viable antigenically d istinct clone o f cells 
dem ands som e explanation.
T h e  dose of antigenic neoplastic cells neces­
sary to stim ulate graft rejection is critical and 
overw helm ing b y  large im p lan ts (24) has its 
corollary in infectious disease. H ow ever the
viability o f a m inute im plant of antigenic 
neoplastic cells (25) and the possibility that 
neoplasm s are the descendants o f a single 
m utant cell (26, 27) com plicates the picture.
T h e  lack o f association betw een antigenic 
change and m alignant change, as evidenced by 
the carcinoge n experim ents (17), suggests that 
loss o f cell specific antigenicity m ay not be a 
universal concom itant of m alignant transform ­
ation. T h e  antigenic change m ay be sm all and 
not provide the necessary stim ulus to sum m ate 
in a hom ograft reaction ( 13 )  or produce physio­
logically poor antigenic groupings(i).
It has also been pointed out that serum 
infusions m ay stim ulate neoplasm  grow th and 
the possibility that antigen expression m ay be 
prevented by blockage of the sites m ust be 
entcrtained  (28).
Lo o kin g to the defence side, the possibility 
o f poor im m unological com petence in patients 
w ith neoplastic disease has been considered 
but, using the present rather crude m ethods, 
no defect has been found in patients with 
early neoplastic disease(5) defects only appear­
ing as the disease progresses (29).
T h e  grow th of antigenically distinct cells in 
the face o f apparently good im m unological 
function rem ains, at present, unexplained but 
it seems probable that it is a m anifestation of 
a m ultifactorial system  invoking m any of the 
above factors, and others as yet undiscovered, 
in different proportions under d ifferent cir­
cum stances.
C I N I C A L  C O N S E Q U E N C E S
1. T h e o r e t i c a l
O ne consequence o f these findings has been 
the concept o f Im m unological Su rveilance 
(26) in w hich the antigenically d istinct m utant 
cell is picked out and destroyed by the 
im m unological m echanism s. Indirect evid­
ence suggesting that this should be seriously 
considered com es from  the recent reports of 
the appearance o f reticuloses quite out of pro­
portion to the expected incidence, in patients 
on continuous im m unological suppression (30, 
3 1) . I t  has also been pointed  o ut that the 
incidence of neoplastic disease rises as im m u n o­
logical function falls in old age (26).
T h is  exciting concept m ay not stand the 
test o f tim e but it seem s likely  that with the 
realisation o f the ab ility  o f one challenge to
in fluence general im m unological responses for 
som e tim e (32) and a better understanding o f 
the phenom enon o f specific tolerance (3) host 
factors m ay find som e place in the explanation 
of the successful grow th of the early neoplasm .
2. Treatment
A  logical consequence of these results has 
been the suggestion that im m unological 
m ethods m ight be used in the treatm ent of 
m alignant disease. In fusions of splenic tissue 
(33) and sensitized lym p h ocytes  (34) have been 
tried in term inal patients w ith som e apparent 
success. T h is  is an interesting phenom enon 
but the lack o f overt im pairm ent of the 
im m unological response in patients w ith early 
neoplasia (5) m ilitates against such an approach 
being of any help when curative procedures 
arc being considered. T h ere  are also dangers 
of the selection o f non-antigenic m utants, 
antibody blockage o f antigen sites, and the 
induction o f tolerance, all o f which have been 
seen in the experim ental m odel (28), and which 
call for a better understanding before m ethods 
of specific response stim ulation can be used 
in m an. F u rth er developm ents arc to be 
expected as the specific nature of the response 
of the im m unological system  when contrasted 
with the system ic adm inistration of a drug 
makes this the theoretical m ethod of choice.
Preventive procedures also call for som e 
attention . Im m unosuppression is the accepted 
treatm ent of the rejection of hum an hom o- 
grafts but the recent appearance o f neoplasia 
(30, 3 1)  soon after the onset o f treatm ent, in 
w hat is a young population , m ust give rise to 
concern. A dvances in tissue typing should 
soon elim inate the necessity fo r this approach 
but it m ust be rem em bered that the thera­
peutic arsenal o f m alignant disease contains 
m any im m unosuppressive agents (35). O ne of 
these, 6-m ercapto-purine has been shown to 
cause tolerance induction to neoplastic anti- 
g ens(36) and, in therapeutic doses, to convert
a tum our rejection reaction into acceptance 
with consequent death o f the an im al(37). T h e  
relative im portance o f the im m unosuppressive 
effect and the therapeutic effect is probably 
w eighted heavily in favour of the latter but 
this should not a llow  the form er effect to be 
ignored.
3. Aetiology
O ne final aspect o f neoplasia which has been 
influenced b y  the study of antigens o n   neo­
plastic cells has been the consideration o f the 
aetiological factors in hum an disease. W ith  
the difference between the neoplasm  specific 
antigens fo llow ing carcinogen induction and 
the group specific antigens seen after viral 
induction in m ind one group of workers, led 
by K leine ( 1 2), have studied the hum an disease 
process in which the possibility o f a viral 
aetiology has been m ost entertained —  B u rk itt ’s 
Lym p h om a. T h e ir  results showed cross re­
activity  betw een the cellu lar antigens o f d iffer­
ent patients. Interpretation has been com pli­
cated by the dem onstration of the presence of 
three d ifferent viruses in lym phom a tissue(38), 
the recognition of the parasitism  of neoplastic 
tissue b y  viruses, and the im plication o f one 
o f the viruses in a com m on benign lym pho- 
re ticular disease (39) but the m ethods involved 
m ay lead to a breakthrough in know ledge 
when these phenom ena are better understood.
CONCLUSION
It  w ould be foolish to claim  that the dem on­
stration of neoplastic cell antigenicity has 
contributed sign ificantly to the treatm e nt of 
hum an disease to date but, apart from  offering 
trem endous hope o f advance in the near future, 
it allows consideration of the problem , not as 
a one-sided invasion, but as a dynam ic situ­
ation in w hich host m echanism s m ay be 
playing a significant part.
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